202
Views
41
CrossRef citations to date
0
Altmetric
Review

Individualized therapy for pericarditis

, , , &
Pages 965-975 | Published online: 10 Jan 2014

References

  • Shabetai R. Recurrent pericarditis: recent advances and remaining questions. Circulation112, 1921–1923 (2005).
  • Shabetai R. Corticosteroids for recurrent pericarditis: on the road to evidence-based medicine. Circulation118, 612–613 (2008).
  • Imazio M, Demichelis B, Parrini I et al. Day-hospital treatment of acute pericarditis: a management program for outpatient therapy. J. Am. Coll. Cardiol.43, 1042–1046 (2004).
  • Imazio M, Demichelis B, Parrini I et al. Management, risk factors, and outcomes in recurrent pericarditis. Am. J. Cardiol.96, 736–739 (2005).
  • Artom G, Koren-Morag N, Spodick DH et al. Pretreatment with corticosteroids attenuates the efficacy of colchicine in preventing recurrent pericarditis: a multi-centre all-case analysis. Eur. Heart J.26, 723–727 (2005).
  • Brucato A, Brambilla G, Adler Y, Spodick DH, Canesi B. Therapy for recurrent acute pericarditis: a rheumatological solution? Clin. Exp. Rheumatol.24, 45–50 (2006).
  • Brucato A, Brambilla G, Moreo A et al. Long-term outcomes in difficult-to-treat patients with recurrent pericarditis. Am. J. Cardiol.98, 267–271 (2006).
  • Imazio M, Cecchi E, Demichelis B et al. Indicators of poor prognosis of acute pericarditis. Circulation115, 2739–2744 (2007).
  • Imazio M, Bobbio M, Cecchi E et al. Colchicine as first-choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial. Arch. Intern. Med.165, 1987–1991 (2005).
  • Imazio M, Bobbio M, Cecchi E et al. Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial. Circulation112, 2012–2016 (2005).
  • Lange RA, Hillis LD. Acute pericarditis. N. Engl. J. Med.351, 2195–2202 (2004).
  • Troughton R, Asher CR, Klein AL. Pericarditis. Lancet363, 717–727 (2004).
  • Little WC, Freeman GL. Pericardial disease. Circulation113, 1622–1632 (2006).
  • Soler-Soler J, Sagristà-Sauleda J, Permanyer-Miralda G. Relapsing pericarditis. Heart90, 1364–1368 (2004).
  • Imazio M, Trinchero R, Shabetai R. Pathogenesis, management, and prevention of recurrent pericarditis. Cardiovasc. Med. (Hagerstown)8, 404–410 (2007).
  • Maisch B, Seferovic PM, Ristic AD et al.; Task Force on the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology. Guidelines on the diagnosis and management of pericardial diseases. Eur. Heart J.25, 587–610 (2004).
  • Permanyer-Miralda G. Acute pericardial disease: approach to the aetiologic diagnosis. Heart90, 252–254 (2004).
  • Permanyer-Miralda G, Sagristá-Sauleda J, Soler-Soler J. Primary acute pericardial disease: a prospective series of 231 consecutive patients. Am. J. Cardiol.56, 623–630 (1985).
  • Zayas R, Anguita M, Torres F et al. Incidence of specific etiology and role of methods for specific etiologic diagnosis of primary acute pericarditis. Am. J. Cardiol.75, 378–382 (1995).
  • Soler-Soler J, Permanyer-Miralda G, Sagristà-Sauleda J. A systematic diagnostic approach to primary acute pericardial disease. The Barcelona experience. Cardiol. Clin.8, 609–620 (1990).
  • Soler-Soler J, Sagrista-Sauleda J, Permanyer-Miralda G. Aetiologic diagnosis of pericardial disease: worthy efforts may not be applied in the appropriate direction. Eur. Heart J.16, 1898–1899 (2006).
  • Spodick DH. Risk prediction in pericarditis: who to keep in hospital? Heart94, 398–399 (2008).
  • Imazio M, Trinchero R. Triage and management of acute pericarditis. Int. J. Cardiol.118, 286–294 (2007).
  • Mayosi BM, Burgess LJ, Doubell AF. Tuberculous pericarditis. Circulation112, 3608–3616 (2005).
  • Mayosi BM. Contemporary trends in the epidemiology and management of cardiomyopathy and pericarditis in sub-Saharan Africa. Heart93, 1176–1183 (2007).
  • Marcolongo R, Russo R, Laveder F, Noventa F, Agostini C. Immunosoppressive therapy prevents recurrent pericarditis. J. Am. Coll. Cardiol.26, 1276–1279 (1995).
  • Man BL, Mok CC. Serositis related to systemic lupus erythematosus: prevalence and outcome. Lupus14, 822–826 (2005).
  • Imazio M, Brucato A, Cumetti D et al. Corticosteroids for recurrent pericarditis: high versus low doses: a nonrandomized observation. Circulation5(118), 667–671 (2008).
  • Maisch B, Ristic A, Pankuweit S. Intrapericardial treatment of autoreactive pericardial effusion with triamcinolone. The way to avoid side effects of systemic corticosteroid therapy. Eur. Heart J.23, 1503–1508 (2002).
  • Maisch B, Ristic AD, Seferovic PM, Spodick DH. Intrapericardial treatment of autoreactive pericarditis with triamcinolon. Successful administration in patients with minimal pericardial effusion. Herz25, 781–786 (2000).
  • Imazio M, Brucato A, Adler Y et al. Prognosis of idiopathic recurrent pericarditis as determined from previously published reports. Am. J. Cardiol.100, 1026–1028 (2007).
  • Imazio M, Brucato A, Trinchero R, Spodick D, Adler Y. Colchicine for pericarditis: hype or hope? Eur. Heart J.30, 532–539 (2009).
  • Adler Y, Finkelstein Y, Guindo J et al. Colchicine treatment for recurrent pericarditis. A decade of experience. Circulation97, 2183–2185 (1998).
  • Guindo J, Rodriguez de la Serna A, Ramio J et al. Recurrent pericarditis : relief with colchicine. Circulation82, 1117–1120 (1990).
  • Adler Y, Zandman-Goddard G, Ravid M et al. Usefulness of colchicine in preventing recurrences of pericarditis. Am. J. Cardiol.73, 916–917 (1994).
  • Millaire A, de Groote P, Decoulx E, Goullard L, Ducloux G. Treatment of recurrent pericarditis with colchicine. Eur. Heart J.15, 120–124 (1994).
  • Ben-Chetrit E, Levy M. Colchicine prophylaxis in familial Mediterranean fever: reappraisal after 15 years. Semin. Arthritis Rheum.20, 241–246 (1991).
  • Zemer D, Livneh A, Danon YL, Pras M, Sohar E. Long term colchicine treatment in children with familial Mediterranean fever. Arthritis Rheum.34, 973–977 (1991).
  • Levy M, Spino M, Read SE. Colchicine: a state-of-the-art review. Pharmacotherapy11, 196–211 (1991).
  • Molad Y. Update on colchicine and its mechanism of action. Curr. Rheumatol. Rep.3, 252–256 (2002).
  • Lange U, Schumann C, Schmidt KL. Current aspects of colchicine therapy. Classical indications and new therapeutic uses. Eur. J. Med. Res.6, 150–160 (2001).
  • Brucato A, Imazio M, Curri S, Palmieri G, Trinchero R. Medical treatment of pericarditis during pregnancy. Int. J. Cardiol. DOI: 10.1016/j.ijcard.2009.03.028 (2009) (Epub ahead of print).
  • Østensen M, Khamashta M, Lockshin M et al. Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res. Ther.8(3), 209 (2006).
  • Ben-Chetrit E, Levy M. Reproductive system in familial Mediterranean fever: an overview. Ann. Rheum. Dis.62, 916–919 (2003).
  • DeValeria PA, Baumgartner WA, Casale AS. Current indications, risks and outcome after pericardiectomy. Ann. Thorac. Surg.52, 219–224 (1991).
  • Sagrista-Sauleda J, Permanyer-Miralda G, Candell-Riera J, Angel J, Soler-Soler J. Transient cardiac constriction: an unrecognized pattern of evolution in effusive acute idiopathic pericarditis. Am. J. Cardiol.59(9), 961–966 (1987).
  • Haley JH, Tajik AJ, Danielson GK, Schaff HV, Mulvagh SL, Oh JK. Transient constrictive pericarditis: causes and natural history. J. Am. Coll. Cardiol.2004 43(2), 271–275.
  • Tsang TS, Barnes ME, Gersh BJ, Bailey KR, Seward JB. Outcomes of clinically significant idiopathic pericardial effusion requiring intervention. Am. J. Cardiol.91, 704–707 (2003).
  • Mills SA, Julian S, Holliday RH. Subxiphoid pericardial window for pericardial effusive disease. J. Cardiovasc. Surg.30, 768–773 (1989).
  • Fakiolas CN, Beldekos DI, Foussas SG. Percutaneous balloon pericardiotomy as a therapeutic alternative for cardiac tamponade and recurrent pericardial effusion. Acta Cardiol.50, 65–70 (1995).
  • Hsu KL, Tsai CH, Chiang FT. Percutaneous balloon pericardiotomy for patients with recurrent pericardial effusion: using a novel double-balloon technique with one long and one short balloon. Am. J. Cardiol.80, 1635–1637 (1997).
  • Wang HJ, Hsu KL, Chiang FT, Tseng CD, Tseng YZ, Liau CS. Technical and prognostic outcomes of double-balloon pericardiotomy for large malignancy-related pericardial effusions. Chest122, 893–899 (2002).
  • Swanson N, Mirza I, Wijesinghe N, Devlin G. Primary percutaneous balloon pericardiotomy for malignant pericardial effusion. Catheter Cardiovasc. Interv.71, 504–507 (2008).
  • Imazio M, Cecchi E, Ierna S, Trinchero R; ICAP Investigators. Investigation on Colchicine for Acute Pericarditis: a multicenter randomized placebo-controlled trial evaluating the clinical benefits of colchicine as adjunct to conventional therapy in the treatment and prevention of pericarditis; study design and rationale. Cardiovasc. Med. (Hagerstown)8, 613–617 (2007).
  • Imazio M, Cecchi E, Ierna S, Trinchero R; CORP Investigators. CORP (COlchicine for Recurrent Pericarditis) and CORP-2 trials – two randomized placebo-controlled trials evaluating the clinical benefits of colchicine as adjunct to conventional therapy in the treatment and prevention of recurrent pericarditis: study design and rationale. J. Cardiovasc. Med. (Hagerstown)8, 830–834 (2007).
  • Imazio M, Cecchi E, Demichelis B et al; COPPS Investigators. Rationale and design of the COPPS trial: a randomised, placebo-controlled, multicentre study on the use of colchicine for the primary prevention of postpericardiotomy syndrome. J. Cardiovasc. Med. (Hagerstown)8, 1044–1048 (2007).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.